Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants Gabe 2024 Diabetes, Obesity and Metabolism Wiley Online Library CagriSema COA Verified Research Peptide Profound Aminos CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine